Can Wegovy Cause Dry Eyes? What the Evidence Shows

Step 1: Understand what the medicine's own data says

Wegovy's UK Patient Information Leaflet and Summary of Product Characteristics list the side effects observed across the STEP clinical trial programme. Nausea, vomiting, diarrhoea, constipation and fatigue feature prominently. Dry eyes do not appear in the formal frequency tables. That absence matters: it means dry eyes were not reported at a rate that reached statistical significance during the trials, not that the symptom is impossible or that patients are imagining it.

The NHS medicines page for semaglutide notes the most common side effects are gastrointestinal. Post-marketing experience, however, is broader than trial data, and clinicians have begun to hear eye-related reports with more regularity as GLP-1 prescribing has scaled. Research into this relationship is ongoing. For now, the honest position is that a causal link between semaglutide and dry eyes has not been confirmed, but it has not been ruled out either. Knowing that distinction helps you interpret your own experience without either dismissing it or alarming yourself unnecessarily.

If you want to read the full list of reported effects, the NHS medicines information for semaglutide is the most accessible UK source, and the eMC lists the complete prescribing information.

Step 2: Consider the other explanations that sit alongside the medicine

Several things happen concurrently when someone starts Wegovy, and separating them is genuinely difficult. Appetite suppression often leads to reduced fluid and food intake in the early weeks, and mild dehydration is a real contributor to tear-film instability. If your diet has shifted significantly, you may also be getting less of the omega-3 fatty acids found in oily fish and nuts that support the lipid layer of the tear film.

Weight loss itself, particularly when it happens relatively quickly, can alter the distribution of fat pads around the orbit. The periorbital fat that cushions the eye and supports eyelid position can reduce, occasionally affecting how completely the eye closes or how effectively it is protected during sleep. This is a recognised phenomenon in people who lose substantial weight by any means.

Reduced calorie intake may also affect the meibomian glands, which produce the oily component of tears. There is a broader look at how semaglutide interacts with ocular surface health at our guide on semaglutide and the eyes, which covers the physiology in more depth. The point here is not to reassure you that the medicine is blameless, but to flag that what you are experiencing may have more than one driver.

Step 3: Manage symptoms sensibly and know when to escalate

For mild grittiness or irritation, the practical steps are straightforward: keep well hydrated, consider preservative-free lubricating eye drops (available from any pharmacy without a prescription), and make sure you are eating enough to sustain good nutrition alongside treatment. Many people find symptoms improve once their body adjusts to the medicine's effects on appetite, typically within the first few weeks of a new dose.

Some people also notice that skin around the eyes feels drier. There is a related discussion on how Wegovy can affect skin moisture if that pattern sounds familiar. Getting slightly ahead of dryness during the first few days after injecting, when GLP-1 activity is peaking, can be practical. Think of it the same way you might think of staying hydrated around a medication that affects fluid balance.

Certain symptoms need faster attention. Blurred vision, sudden changes in how clearly you can see, pain inside the eye, or significant redness should not be attributed to the medicine and left. These may indicate something unrelated that needs assessment in its own right. The NHS semaglutide medicines page advises contacting a healthcare professional if you notice unexpected vision changes during treatment. If you are uncertain whether your symptoms qualify as urgent, contact your prescriber or pharmacist for a quick steer.

Step 4: Keep your prescriber informed

Eye symptoms during Wegovy treatment are worth documenting and mentioning at your next review, even if they have largely settled. Prescribers build a fuller picture of how a medicine behaves in the real world partly from what patients report, and that information feeds into post-marketing safety monitoring. In the UK, patients can also report suspected side effects directly through the MHRA's Yellow Card scheme, which is how post-approval safety signals are tracked.

If your eyes are persistently uncomfortable and you are wondering whether to continue treatment, a prescriber is the right person to weigh that up with you, not a forum. There is more context on how Wegovy can affect different aspects of ocular health at our overview of Wegovy and eye health, and a closer look at itching specifically at the page on Wegovy and itchy eyes. A broader understanding of the medicine, including how it works and who it is suitable for, is covered on the Wegovy overview page. Cost is a common practical question too, and the Wegovy cost page sets out what to expect from private treatment.

If you are considering starting Wegovy and want a clinical team to review your full medical picture, including any pre-existing eye conditions, check your eligibility through a free consultation with our GPhC-registered prescribers.